Lowest-Rated StocksLowest-RatedNYSE:BAX Baxter International (BAX) Stock Price, News & Analysis $33.71 +0.40 (+1.20%) (As of 11/29/2024 04:45 PM ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends About Baxter International Stock (NYSE:BAX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Baxter International alerts:Sign Up Key Stats Today's Range$33.11▼$33.8150-Day Range$31.71▼$39.0052-Week Range$31.60▼$44.01Volume2.93 million shsAverage Volume4.11 million shsMarket Capitalization$17.21 billionP/E Ratio168.56Dividend Yield2.02%Price Target$40.91Consensus RatingHold Company OverviewBaxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.Read More… Could This Tiny Device Help You Make an Extra $30k a Year? (Ad)I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.Click here to see the details because I believe a lot of people will get rich. Baxter International Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks81st Percentile Overall ScoreBAX MarketRank™: Baxter International scored higher than 81% of companies evaluated by MarketBeat, and ranked 235th out of 964 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.1 / 5Analyst RatingHold Consensus RatingBaxter International has received a consensus rating of Hold. The company's average rating score is 2.18, and is based on 3 buy ratings, 7 hold ratings, and 1 sell rating.Amount of Analyst CoverageBaxter International has only been the subject of 2 research reports in the past 90 days.Read more about Baxter International's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth31.31% Earnings GrowthEarnings for Baxter International are expected to grow by 31.31% in the coming year, from $1.98 to $2.60 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Baxter International is 168.56, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 121.09.Price to Earnings Ratio vs. SectorThe P/E ratio of Baxter International is 168.56, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 110.56.Price to Earnings Growth RatioBaxter International has a PEG Ratio of 13.23. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioBaxter International has a P/B Ratio of 2.17. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Baxter International's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.50% of the outstanding shares of Baxter International have been sold short.Short Interest Ratio / Days to CoverBaxter International has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Baxter International has recently increased by 11.51%, indicating that investor sentiment is decreasing significantly. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldBaxter International pays a meaningful dividend of 3.48%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthBaxter International does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Baxter International is 340.00%. Payout ratios above 75% are not desirable because they may not be sustainable.Dividend SustainabilityBased on earnings estimates, Baxter International will have a dividend payout ratio of 26.15% next year. This indicates that Baxter International will be able to sustain or increase its dividend.Read more about Baxter International's dividend. Sustainability and ESG4.0 / 5Environmental Score-1.95 Percentage of Shares Shorted2.50% of the outstanding shares of Baxter International have been sold short.Short Interest Ratio / Days to CoverBaxter International has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Baxter International has recently increased by 11.51%, indicating that investor sentiment is decreasing significantly. News and Social Media1.2 / 5News Sentiment0.10 News SentimentBaxter International has a news sentiment score of 0.10. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.87 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Baxter International this week, compared to 8 articles on an average week.Search InterestOnly 9 people have searched for BAX on MarketBeat in the last 30 days. This is a decrease of -53% compared to the previous 30 days.MarketBeat FollowsOnly 6 people have added Baxter International to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Baxter International insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.21% of the stock of Baxter International is held by insiders.Percentage Held by Institutions90.19% of the stock of Baxter International is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Baxter International's insider trading history. Receive BAX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Baxter International and its competitors with MarketBeat's FREE daily newsletter. Email Address BAX Stock News HeadlinesBaxter International: Dividend Cut Because Of Restructuring November 29 at 9:02 PM | talkmarkets.comAfter Helene, NC school buses came to the rescue for McDowell County company & employeesNovember 29 at 6:45 AM | msn.comCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.December 1, 2024 | Brownstone Research (Ad)Local healthcare facilities react to IV fluid shortageNovember 28 at 12:20 AM | msn.comTrump's tariffs could raise the cost of generic drugs in the U.S.November 24, 2024 | msn.comRep. Debbie Wasserman Schultz Buys Shares of Baxter International Inc. (NYSE:BAX)November 23, 2024 | americanbankingnews.comIV fluid shortage after hurricane hit Baxter International plant prompts hospitals to conserveNovember 22, 2024 | chicago.suntimes.comBaxter International (BAX) Announces Board Changes with Resignation of DirectorNovember 22, 2024 | gurufocus.comSee More Headlines BAX Stock Analysis - Frequently Asked Questions How have BAX shares performed this year? Baxter International's stock was trading at $38.66 at the start of the year. Since then, BAX shares have decreased by 12.8% and is now trading at $33.71. View the best growth stocks for 2024 here. How were Baxter International's earnings last quarter? Baxter International Inc. (NYSE:BAX) announced its earnings results on Friday, November, 8th. The medical instruments supplier reported $0.80 EPS for the quarter, topping the consensus estimate of $0.78 by $0.02. Baxter International's revenue was up 3.8% compared to the same quarter last year. Read the conference call transcript. Does Baxter International have any subsidiaries? The following companies are subsidiaries of Baxter International: Cheetah Medical, ApaTech Limited, Baxter AO, Baxter Belgium SPRL, Baxter (China) Investment Co. Ltd, Baxter Company Ltd, Baxter Corporation (Canada), and more. Who are Baxter International's major shareholders? Baxter International's top institutional shareholders include Geode Capital Management LLC (2.38%), Thompson Siegel & Walmsley LLC (0.37%), Coho Partners Ltd. (0.30%) and National Pension Service (0.23%). Insiders that own company stock include Jeanne K Mason, Albert P L Stroucken, Jacqueline Kunzler and Brian Stevens. View institutional ownership trends. How do I buy shares of Baxter International? Shares of BAX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Baxter International own? Based on aggregate information from My MarketBeat watchlists, some other companies that Baxter International investors own include Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), Exxon Mobil (XOM), Chevron (CVX), JPMorgan Chase & Co. (JPM) and Intel (INTC). Company Calendar Ex-Dividend for 10/1 Dividend8/30/2024Dividend Payable10/01/2024Last Earnings11/08/2024Ex-Dividend for 1/2 Dividend11/29/2024Today12/01/2024Fiscal Year End12/31/2024Dividend Payable1/02/2025Next Earnings (Estimated)2/13/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & medical instruments Sub-IndustryHealth Care Equipment Current SymbolNYSE:BAX CUSIP07181310 CIK10456 Webwww.baxter.com Phone(224) 948-2000Fax224-948-1813Employees60,000Year Founded1931Price Target and Rating Average Stock Price Target$40.91 High Stock Price Target$54.00 Low Stock Price Target$30.00 Potential Upside/Downside+21.4%Consensus RatingHold Rating Score (0-4)2.18 Research Coverage11 Analysts Profitability EPS (Most Recent Fiscal Year)$0.20 Trailing P/E Ratio168.56 Forward P/E Ratio17.03 P/E Growth13.23Net Income$2.66 billion Net Margins0.77% Pretax Margin-0.50% Return on Equity18.30% Return on Assets5.43% Debt Debt-to-Equity Ratio1.31 Current Ratio1.43 Quick Ratio1.09 Sales & Book Value Annual Sales$15.06 billion Price / Sales1.14 Cash Flow$5.31 per share Price / Cash Flow6.35 Book Value$15.56 per share Price / Book2.17Miscellaneous Outstanding Shares510,588,000Free Float509,516,000Market Cap$17.21 billion OptionableOptionable Beta0.60 Social Links 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report This page (NYSE:BAX) was last updated on 12/1/2024 by MarketBeat.com Staff From Our PartnersThe latest trend in real estateThese vacation homes are often expensive to maintain and vacant 90% of the year. But thanks to co-ownership, t...Pacaso | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredBofA is watching for a market topU.S. tech stocks have soared so high for so long that they're no longer just minting new millionaires... Th...Chaikin Analytics | SponsoredPaypal, Tesla, SpaceX… Elon's next project is bigger than them allIn February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | SponsoredThis Crisis Could Be Worse Than 2008Underneath the surface, cracks are forming. Cracks that threaten to shatter everything we know. America ...Behind the Markets | SponsoredYou’re invited! See my NEWEST trading strategyThis could easily be the most lucrative new trading strategy of 2025... So you’re not going to want to miss...Monument Traders Alliance | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Baxter International Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Baxter International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BAX Stock Alerts